Targacept to Present at the 2012 Deutsche Bank dbAccess BioFEST

[at noodls] – Winston-Salem, NC November 27, 2012 Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that members of its executive management … more

View todays social media effects on TRGT

View the latest stocks trending across Twitter. Click to view dashboard